Know Cancer

or
forgot password

    • cancer clinical trials in birmingham, AL

    • Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Childhood Lymphocyte Predominant Hodgkin Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage II Childhood Hodgkin Lymphoma
    Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel
    Achieve Clinical Research
    Birmingham, Alabama 35209
    Non-small Cell Lung Cancer
    S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Melanoma (Skin)
    Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Breast Cancer
    Nutrition Intervention in Treating Women With Breast Cancer
    University of Alabama Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Breast Cancer
    Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
    University of Alabama Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Prostate Cancer
    Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Breast Cancer
    Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Lung Cancer
    Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
    Alabama Therapeutics CRS
    Birmingham, Alabama 35294
    HIV Infections, Sexually Transmitted Diseases
    Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Head and Neck Cancer
    Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma
    University of Alabama Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Melanoma (Skin)
    Radiation Therapy With or Without Bicalutamide in Treating Patients With Stage II, Stage III, or Recurrent Prostate Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Prostate Cancer
    Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
    University of Alabama Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Sarcoma
    Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
    University of Alabama Comprehensive Cancer Center

    Trial Locations
    University of Alabama Comprehensive Cancer Center
    Veterans Affairs Medical Center - Birmingham
    Head and Neck Cancer, Oral Complications
    Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer
    University of Alabama Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
    Veterans Affairs Medical Center - Birmingham
    Birmingham, Alabama 35233
    Leukemia
    Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Fever, Sweats, and Hot Flashes, Neutropenia, Unspecified Childhood Solid Tumor, Protocol Specific
    Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Childhood Germ Cell Tumor, Drug/Agent Toxicity by Tissue/Organ, Extragonadal Germ Cell Tumor, Ovarian Cancer
    Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Breast Cancer
    Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer
    University of Alabama Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Lung Cancer
    Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Bladder Cancer
    Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Brain and Central Nervous System Tumors
    Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
    University of Alabama Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Lymphoma
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Sarcoma
    Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia
    University of Alabama Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Leukemia
    Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Prostate Cancer
    Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Melanoma (Skin)
    Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Head and Neck Cancer
    Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
    Veterans Affairs Medical Center - Birmingham
    Birmingham, Alabama 35233
    Leukemia
    STI571 in Treating Patients With Recurrent Leukemia
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Leukemia
    Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Prostate Cancer
    Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Breast Cancer
    Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Brain and Central Nervous System Tumors
    Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System
    University of Alabama Comprehensive Cancer Center

    Trial Locations
    University of Alabama Comprehensive Cancer Center
    Children's Hospital of Alabama
    Herpes Simplex
    Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Brain and Central Nervous System Tumors
    Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Leukemia
    Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Cognitive/Functional Effects, Metastatic Cancer, Radiation Toxicity
    Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Head and Neck Cancer
    AG2037 in Treating Patients With Advanced, Metastatic, or Recurrent Solid Tumors
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Unspecified Adult Solid Tumor, Protocol Specific
    Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Lymphoma
    Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Lung Cancer
    Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
    University of Alabama at Birmingham Preventive Medicine
    Birmingham, Alabama 35294-4410
    Alzheimer Disease
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Breast Cancer
    Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Breast Cancer
    Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Leukemia
    PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Melanoma (Skin)
    Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Childhood Embryonal Tumor, Childhood Extracranial Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor, Childhood Malignant Ovarian Germ Cell Tumor, Childhood Malignant Testicular Germ Cell Tumor, Childhood Teratoma, Ovarian Embryonal Carcinoma, Ovarian Yolk Sac Tumor, Stage II Malignant Testicular Germ Cell Tumor, Stage IIA Ovarian Germ Cell Tumor, Stage IIB Ovarian Germ Cell Tumor, Stage IIC Ovarian Germ Cell Tumor, Stage III Malignant Testicular Germ Cell Tumor, Stage IIIA Ovarian Germ Cell Tumor, Stage IIIB Ovarian Germ Cell Tumor, Stage IIIC Ovarian Germ Cell Tumor, Testicular Choriocarcinoma and Yolk Sac Tumor, Testicular Embryonal Carcinoma
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Breast Cancer
    Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Lung Cancer
    Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Colorectal Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Endometrial Cancer
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Breast Cancer
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Kidney Cancer